| Literature DB >> 12926978 |
Samuel Gettler1, Marti Rothe, Caron Grin, Jane Grant-Kels.
Abstract
The optimal treatment of pyoderma gangrenosum includes a combination of local wound care and systemic medications. Oral and pulse intravenous corticosteroids have traditionally been the most commonly recommended first-line systemic therapies. Cyclosporine, with or without corticosteroids, has more recently emerged as a first-line systemic treatment. A multitude of immunosuppressive and immune-modulating medications, as well as antimicrobial agents with anti-inflammatory properties have also been widely prescribed. Often, it is difficult to achieve control of aggressive cases of pyoderma gangrenosum, necessitating administration of a combination of systemic therapies. Furthermore, patients recalcitrant to one or many medications are frequently reported. Concomitant disease, intolerance to a class of medications, and the patient's response to prior therapies can help guide a practitioner in choosing the optimal treatment of pyoderma gangrenosum.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12926978 DOI: 10.2165/00128071-200304090-00002
Source DB: PubMed Journal: Am J Clin Dermatol ISSN: 1175-0561 Impact factor: 7.403